Warner Chilcott

Warner Chilcott (formerly Galen) was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis (now Allergan).

Warner Chilcott plc
IndustryPharmaceutical industry
Founded1968 (1968)
FounderAllen McClay
DefunctOctober 1, 2013 (October 1, 2013)
FateAcquired by Actavis (now Allergan)
HeadquartersRockaway, New Jersey

History

Galen

In 1968, Sir Allen McClay founded Galen, a sales and marketing organization focused on branded pharmaceutical products in the United Kingdom and the Republic of Ireland.[1]

In 1997, the company listed its shares on the London Stock Exchange and the Irish Stock Exchange.[1]

Warner Chilcott

Warner Chilcott was the generic drug business of Warner–Lambert.

In 1996, it was sold to Nale Laboratories P.L.C.[2]

In 2004, the company was acquired by several private equity firms. In 2006, it became a public company via an initial public offering.[3]

Merger of Galen and Warner Chilcott

In 2000, Galen acquired Warner Chilcott and listed its American depositary receipts on NASDAQ.[1]

In 2004, the company changed its name from Galen to Warner Chilcott.[4]

Post-merger

In August 2004, the company prevailed in a patent case by Teva Pharmaceutical Industries related to Sarafem (Fluoxetine).[5] On May 19, 2006, the company received approval from the Food and Drug Administration for Sarafem.[6]

On October 30, 2009, the company acquired the prescription drug business of Procter & Gamble for $3.1 billion.[7]

On October 1, 2013, the company was acquired by Actavis (now Allergan).[8]

References
  1. Carroll, Steven (October 20, 2009). "Warner Chilcott: company history". The Irish Times.
  2. "WARNER-LAMBERT TO SELL GENERIC UNIT TO NALE". The New York Times. Bloomberg Business News. March 2, 1996.
  3. "Warner Chilcott's I.P.O. Prices Below Expected Range". The New York Times. September 21, 2006.(subscription required)
  4. "Galen to change name to Warner Chilcott". The Irish Times. May 12, 2004.
  5. Meland, Marius (August 6, 2004). "Warner Chilcott Prevails Vs. Teva In Sarafem Patent Suit". Law360.
  6. "Sarafem (fluoxetine hydrochloride) Tablets". Food and Drug Administration. May 19, 2006.
  7. "Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business" (Press release). Evaluate Group. October 30, 2009.
  8. "Actavis Completes Warner Chilcott Acquisition" (Press release). PR Newswire. October 1, 2013.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.